Citation

Barbara Laughton, Paul E Palumbo, Michael J Boivin, Mark F. Cotton, Mutsa Bwakura-Dangarembizi, Avy Violari, Itziar Familiar-Lopez, Linda Barlow-Mosha, Portia Kamthunzi, Katie Mccarthy, Patrick Jean-Philippe, Lee Fairlie, Miriam Chernoff. Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa. Frontiers in Pediatrics. 2022. 10: 899002. PMID: 35989995

Citation

Sikorskii A, Atuhaire P, Ogwang LW, Mutebe A, Katumbi C, Maliwichi L, Familiar I, Taha T, Boivin MJ, PROMISE-NEURODEV study team, Fowler MG, Aizire J. Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age.. AIDS. 2022. 36: 573-582. PMID: 34750297

Citation

Hughes MD, Shah NS, Upton C, Gupta A, Narunsky K, Hesseling AC, Mendoza-Ticona A, ACTG A5300/IMPAACT 2003/PHOENix Feasibility Study Team, Khajenoori S, Gonzales P, Badal-Faesen S, Shenje J, Omoz-Oarhe A, Rouzier V, Garcia-Prats AJ, Demers AM, Naini L, Smith E, Kim S, Churchyard G, Wu X, Swindells S. High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis. Pediatric Infectious Disease Journal. 2022. 41: 194-202. PMID: 35239624

Citation

Penn-Nicholson A, Toefy A, Erasmus M, Hanekom WA, Scriba TJ, Lai RPJ, Marais S, Fletcher HA, Meintjes G, Wilkinson RJ, Cotton MF, Pahwa S, Cameron MJ, Nemes E, Mbandi SK, Painter H. Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.. European Journal of Immunology. 2022. 52: 1112-1119. PMID: 35398886

Citation

Jessica P. Liu, Andrew Wiznia, Kathryn P. Gray, IMPAACT P1093 Team, Kathleen George, Nicole Montañez, Stephanie Popson, Ann M. Buchanan, Mattie Bartlett, Dale Dayton, Patricia Anthony, Cynthia Brothers, Cynthia Vavro, Rajendra Singh, Lucy Koech, Tichaona Vhembo, Theodore D. Ruel, Rohan Hazra, Edward P. Acosta, Ellen Townley. Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial. Lancet HIV. 2022. PMID: 35489377

Citation

Brookie M Best, Edmund Capparelli, Jiajia Wang, David Shapiro, Nahida Chakhtoura, Mark Mirochnick, Ahizechukwu C Eke, Regis Kreitchmann, Alice Stek, IMPAACT P1026s protocol team. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens. Contraception. 2022. 105: 67-74. PMID: 34407424

Citation

Lubbe Wiesner, Buyisile Mkhize, Tracy Kellermann, Jennifer Norman, Sandra Castel, Anton Joubert, Kelly E. Dooley, Jyoti S. Mathad. Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk. Journal of Pharmaceutical and Biomedical Analysis. 2022. 215PMID: 35462285

Citation

Kevin Butler, Marion G. Peters, Tichaona Vhembo, Dhayendre Moodley, Vani Govender, Neaka Mohtashemi, Hannah Ship, Philippa Musoke, Dingase Dula, Kathy George, Nahida Chakhtoura, Mary G. Fowler, Judith S. Currier, Debika Bhattacharya, Flavia Matovu Kiweewa, Camlin Tierney. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection. Journal of AIDS. 2022. 91: 79-84. PMID: 35621877

Citation

Petronella Muresan, Mariam Aziz, Matthew S. Kelly, Lijuan Yang, Elizabeth J. McFarland, Cindy Luongo, Charlotte Perlowski, Peter L. Collins, Jennifer Libous, Ursula J. Buchholz, Jennifer Oliva, IMPAACT 2018 Study Team, Patrick Jean-Philippe, Jack Moye Jr., Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Coleen K. Cunningham, Mary Paul, Ruth A. Karron, Jaime G. Deville. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children. Journal of Infectious Diseases. 2022. 226: 2069-2078. PMID: 35732186

Citation

Paula Britto, Amita Gupta, Priya Jayachandran, Kelly E Dooley, Lubbe Wiesner, IMPAACT 2001 Study Team, Grace Montepiedra, Jennifer Norman, Nan Zhang, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Jyoti S Mathad, Amphan Chalermchockcharoentkit, Rada Savic, Portia Kamthunzi. Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 2022. 74: 1604-1613. PMID: 34323955